Furthermore, hallmarks for E2F and MYC targets were also enriched in shScr organoids (Figure 5C), well correlated with molecular signatures enriched in EN1‐high patients from TCGA‐PAAD dataset (Figure 1J). The gene discussed is MYC; the disease is pancreatic adenocarcinoma.